Literature DB >> 29264726

Antireflux Surgery and Barrett's Esophagus: Myth or Reality?

Fernando A M Herbella1, Francisco Schlottmann2, Marco G Patti2.   

Abstract

BACKGROUND: It may seem questionable if antireflux surgery still has a role in the management of patients with Barrett's esophagus (BE) in the current era when antireflux surgery is facing a steady decline, obesity is increasing, pharmacologic treatment for gastroesophageal reflux disease (GERD) is in its splendor, and endoscopic techniques are used more frequently. It is questionable if patients with BE should be operated to stop GERD and to prevent cancer. The aim of this study was to determine the role of antireflux surgery in patients with BE.
METHODS: Literature review.
RESULTS: The role of antireflux operations is, in fact, very controversial and neglected. BE is a different phenotype of GERD with a distinct pathophysiology linked to severe reflux of bile and acid, due to a marked anatomic disruption of the gastroesophageal barrier. Published series show that a fundoplication adequately controls GERD and symptoms in BE patients. A fundoplication (or even better a bile diversion antireflux procedure) may prevent esophageal adenocarcinoma.
CONCLUSIONS: In conclusion, a fundoplication efficiently controls GERD and symptoms in BE patients. A fundoplication (or even better a bile diversion procedure) may also prevent esophageal adenocarcinoma.

Entities:  

Mesh:

Year:  2018        PMID: 29264726     DOI: 10.1007/s00268-017-4394-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  42 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Radiofrequency ablation for Barrett's esophagus, for whom and by whom?

Authors:  Roos E Pouw; Jacques J G H M Bergman
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

3.  The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.

Authors:  Corey S Johnson; Brian E Louie; Aaron Wille; Christy M Dunst; Stephanie G Worrell; Steven R DeMeester; Jessica Reynolds; Joe Dixon; John C Lipham; Michal Lada; Jeffrey H Peters; Thomas J Watson; Alexander S Farivar; Ralph W Aye
Journal:  J Gastrointest Surg       Date:  2015-03-05       Impact factor: 3.452

Review 4.  Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife?

Authors:  Tony S Brar; Peter V Draganov; Dennis Yang
Journal:  Dig Dis Sci       Date:  2016-10-28       Impact factor: 3.199

5.  Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease.

Authors:  G M Campos; S R DeMeester; J H Peters; S Oberg; P F Crookes; J A Hagen; C G Bremner; L F Sillin; R J Mason; T R DeMeester
Journal:  Arch Surg       Date:  2001-11

6.  Long-term outcome of antireflux surgery in patients with Barrett's esophagus.

Authors:  W L Hofstetter; J H Peters; T R DeMeester; J A Hagen; S R DeMeester; P F Crookes; P Tsai; F Banki; C G Bremner
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

Review 7.  The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.

Authors:  David E Fleischer; Robert Odze; Bergein F Overholt; John Carroll; Kenneth J Chang; Ananya Das; John Goldblum; Daniel Miller; Charles J Lightdale; Jeffrey Peters; Richard Rothstein; Virender K Sharma; Daniel Smith; Victor Velanovich; Herbert Wolfsen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-04-20       Impact factor: 3.199

Review 8.  Pathophysiology of Gastroesophageal Reflux Disease.

Authors:  Mariano A Menezes; Fernando A M Herbella
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

9.  The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus.

Authors:  Ellen Morrow; Daniel Bushyhead; Eelco Wassenaar; Marcelo Hinojosa; Maximiliano Loviscek; Carlos Pellegrini; Brant Oelschlager
Journal:  Surg Endosc       Date:  2014-06-17       Impact factor: 4.584

Review 10.  The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

Authors:  Eugene Y Chang; Cynthia D Morris; Ann K Seltman; Robert W O'Rourke; Benjamin K Chan; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

View more
  1 in total

1.  One-Anastomosis and Roux-en-Y Gastric Bypass Promote Similar Weight Loss, Patient Satisfaction, Quality of Life, Inflammation Grade, and Cellular Damage in the Esophagus and Gastric Pouch in a Short-term Follow-up.

Authors:  Rafael C Katayama; Carlos H Arasaki; Fernando A M Herbella; Ricardo A Neto; Gaspar de Jesus Lopes Filho
Journal:  J Obes Metab Syndr       Date:  2021-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.